HeartSciences Inc.
HSCS | NASDAQ
$4.68
-$0.52 (-10.00%)
At close: Sep 21, 2026, 4:00 PM ET
$4.41
-$0.27 (-5.81%)
Pre-market:
Sep 22, 2026, 4:25 AM ET
Fiscal Year Period Ending | FY 2026 Dec 30, 2025 | FY 2025 Apr 29, 2025 | FY 2024 Apr 29, 2024 | FY 2023 Apr 29, 2023 | FY 2022 Apr 29, 2022 | FY 2021 Apr 29, 2021 |
|---|---|---|---|---|---|---|
Revenue | 4.32K | 4.35K | 18.6K | 5.15K | 14.37K | 25.6K |
Cost of Revenue | 133.12K | 129.84K | 101.21K | 29.71K | 34.46K | 44.28K |
Gross Profit | -128.8K | -125.49K | -82.61K | -24.56K | -20.08K | -18.67K |
Operating Income | -8.41M | -8.35M | -6.31M | -6.11M | -4.71M | -2.57M |
Interest Income | n/a | 87.8K | n/a | n/a | n/a | n/a |
Pretax Income | -9.14M | -8.77M | -6.61M | -6.35M | -4.83M | -2.45M |
Net Income | -9.14M | -8.77M | -6.61M | -6.35M | -4.83M | -2.45M |
Selling & General & Admin | 5.58B | 3.84M | 3.34M | 3.63M | 1.69M | 841.01K |
Research & Development | 2.84B | 4.39M | 2.88M | 2.46M | 3M | 1.71M |
Other Expenses | -8.41B | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 8.28M | 8.23M | 6.22M | 6.09M | 4.69M | 2.55M |
Interest Expense | 753.04K | 500.45K | 354.08K | 243.17K | 371.62K | 132.45K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.42M | 8.36M | 6.32M | 6.12M | 4.72M | 2.59M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.63M | 938.26K | 352.52K | 79.51K | 33.19K | 33.14K |
Shares Outstanding (Diluted) | 2.63M | 938.26K | 352.52K | 79.51K | 33.19K | 33.14K |
EPS (Basic) | -3.48 | -9.34 | -18.74 | -79.92 | -145.48 | -77.89 |
EPS (Diluted) | -3.48 | -9.34 | -18.74 | -79.92 | -145.48 | -77.89 |
EBITDA | -8.41M | -8.22M | -6.16M | -6.08M | -4.43M | -2.29M |
EBIT | -8.41M | -8.35M | -6.25M | -6.11M | -4.46M | -2.32M |
Depreciation & Amortization | n/a | 127.96K | 95.13K | 26.92K | 26.57K | 33.61K |
Add to Watchlist
Select watchlists to add or remove HSCS